Ornithine-δ-aminotransferase clinical trials at UCSF

1 research study open to eligible people

Ornithine-ﾎｴ-aminotransferase is an enzyme involved in amino acid metabolism. UCSF is investigating how changes in this enzyme affect eye health and ornithine levels. These clinical trials study the link between enzyme mutations and retinal degeneration.

Showing trials for

  • Gyrate Atrophy Ocular and Systemic Study

    open to eligible people ages 12 years and up

    The Gyrate Atrophy Ocular and Systemic Study characterizes the natural history of ornithine levels and retinal degeneration (RD) associated with disease-causing OAT variants in the presence of standard care dietary treatment regimens over 4 years. The research goal is to understand the impact of OAT mutations on plasma ornithine levels and retinal degeneration. Funding Source- FDA OOPD

    San Francisco, California and other locations

Last updated: